Miromatrix Medical
Stock Forecast, Prediction & Price Target
Miromatrix Medical Financial Estimates
Miromatrix Medical Revenue Estimates
Miromatrix Medical EBITDA Estimates
Miromatrix Medical Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2020 | 12/31/2021 | 12/31/2022 | 12/31/2025 | |||
Revenue
% change YoY
| $46.53K N/A | $33.06K -28.93% | $953.47K 2783.53% | Avg: $13.5K Low: $14.36K High: $12.65K avg. -98.58% | |||
Net Income
% change YoY
| $-8.71M N/A | $-14.95M -71.58% | $-30.00M -100.64% | Avg: $-54.97M Low: $-22.38M High: $-22.17M avg. -83.20% | |||
EBITDA
% change YoY
| $-11.44M N/A | $-16.78M -46.67% | $-29.91M -78.17% | Avg: $-13.5K Low: $-14.36K High: $-12.65K avg. 99.95% | |||
EPS
% change YoY
| -$0.82 N/A | -$1.3 -58.53% | -$1.45 -11.53% | Avg: -$1.08 Low: -$1.08 High: -$1.07 avg. 25.86% | |||
Operating Expenses
% change YoY
| $8.81M N/A | $16.09M 82.68% | $30.69M 90.68% | Avg: $0 Low: $0 High: $0 avg. -100% | |||
FAQ
What is Miromatrix Medical stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -83.20% in 2025-2025.
We have gathered data from 2 analysts. Their low estimate is -22.38M, average is -54.97M and high is -22.17M.
What is Miromatrix Medical stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of -98.58% in 2025-2025.
We have gathered data from 2 analysts. Their low revenue estimate is $14.36K, average is $13.5K and high is $12.65K.
What is Miromatrix Medical stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 25.86% in 2025-2025.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$1.08, average is -$1.08 and high is $-1.07.
What is the best performing analyst?
In the last twelve months analysts have been covering Miromatrix Medical stock. The most successful analyst is Matt O'Brien.